Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer
出版年份 2020 全文链接
标题
Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer
作者
关键词
-
出版物
Biomed Research International
Volume 2020, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2020-10-22
DOI
10.1155/2020/2148253
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
- (2019) Constantin N. Baxevanis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
- (2019) Wei Liu et al. CANCER SCIENCE
- Heat shock proteins create a signature to predict the clinical outcome in breast cancer
- (2019) Marta Klimczak et al. Scientific Reports
- Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target
- (2019) Vida Hashemi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- GeneMANIA update 2018
- (2018) Max Franz et al. NUCLEIC ACIDS RESEARCH
- TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
- (2018) Danilo Matassa et al. Genes
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
- (2018) Kenichi Harano et al. PLoS One
- Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy
- (2017) Michal Jarzab et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Mechanisms of Hsp90 regulation
- (2016) C. Prodromou BIOCHEMICAL JOURNAL
- Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis
- (2016) Jiafeng Shou et al. BMC CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94
- (2016) Ephraim A. Ansa-Addo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- HSP90AB1: Helping the good and the bad
- (2016) Michael Haase et al. GENE
- Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
- (2016) Samantha Burugu et al. Breast Cancer
- Relevance of tumor-infiltrating lymphocytes in breast cancer
- (2015) Sathana Dushyanthen et al. BMC Medicine
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- Immune microenvironment as a factor of breast cancer progression
- (2015) Anatolii Romaniuk et al. Diagnostic Pathology
- Maximizing the Therapeutic Potential of HSP90 Inhibitors
- (2015) L. M. Butler et al. MOLECULAR CANCER RESEARCH
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Systematic pan-cancer analysis of tumour purity
- (2015) Dvir Aran et al. Nature Communications
- Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy
- (2015) D. A. Proia et al. Cancer Immunology Research
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells
- (2014) Timothy J. Haggerty et al. PLoS One
- A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors
- (2014) Maria Isabel Carvalho et al. Biomed Research International
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
- (2013) Xiaoqiang Tang CANCER LETTERS
- Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosis
- (2013) Anna Dubaniewicz HUMAN IMMUNOLOGY
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- Molecular Pathways: Targeting Hsp90--Who Benefits and Who Does Not
- (2012) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival
- (2012) Thomas R. Cawthorn et al. PLoS One
- A Screening Assay to Identify Agents That Enhance T-Cell Recognition of Human Melanomas
- (2011) Timothy J. Haggerty et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started